Connection
Margaret Macy to Receptors, CXCR4
This is a "connection" page, showing publications Margaret Macy has written about Receptors, CXCR4.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.035 |
|
|
|
-
Cooper TM, Sison EAR, Baker SD, Li L, Ahmed A, Trippett T, Gore L, Macy ME, Narendran A, August K, Absalon MJ, Boklan J, Pollard J, Magoon D, Brown PA. A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03). Pediatr Blood Cancer. 2017 Aug; 64(8).
Score: 0.035